
11 - 50 employés
🧬 Biotechnologie
🏥 Santé
🤖 Intelligence artificielle
💰 Grant en 2022-01
Biotechnology • Healthcare • Artificial Intelligence
Nous sommes une entreprise de biotechnologie en phase clinique qui révolutionne le processus de découverte et de développement de nouveaux traitements peptidiques pour les patients atteints de maladies graves et potentiellement mortelles. En combinant le potentiel inexploité de la biologie des peptides avec la puissance de l'apprentissage automatique, nous nous efforçons d'élargir notre approche de conception de médicaments et d'inaugurer la prochaine génération de thérapeutiques peptidiques grâce à une ingénierie et une conception de précision. Notre principal traitement peptidique, PLG0206, est un nouvel agent anti-infectieux à large spectre actuellement étudié dans des essais cliniques comme traitement potentiel pour l'infection des articulations prothétiques, une condition historiquement difficile à traiter avec un besoin sévère non satisfait.
🕒 il y a 1 mois
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

11 - 50 employés
🧬 Biotechnologie
🏥 Santé
🤖 Intelligence artificielle
💰 Grant en 2022-01
Biotechnology • Healthcare • Artificial Intelligence
Nous sommes une entreprise de biotechnologie en phase clinique qui révolutionne le processus de découverte et de développement de nouveaux traitements peptidiques pour les patients atteints de maladies graves et potentiellement mortelles. En combinant le potentiel inexploité de la biologie des peptides avec la puissance de l'apprentissage automatique, nous nous efforçons d'élargir notre approche de conception de médicaments et d'inaugurer la prochaine génération de thérapeutiques peptidiques grâce à une ingénierie et une conception de précision. Notre principal traitement peptidique, PLG0206, est un nouvel agent anti-infectieux à large spectre actuellement étudié dans des essais cliniques comme traitement potentiel pour l'infection des articulations prothétiques, une condition historiquement difficile à traiter avec un besoin sévère non satisfait.
• Develop and execute Peptilogics' investor-relations strategy, including calendar planning, proactive outreach, content creation, and engagement tracking • Serve as primary point of contact for current and prospective investors, analysts, and relevant media • Own development and maintenance of IR materials, investor decks, fact sheets, financing announcements, press releases, and Q&A documents • Manage public-facing channels, including the corporate website and social platforms, ensuring timely, accurate, compliant, and consistent messaging • Coordinate investor and analyst engagement across conferences, non-deal roadshows, and industry events • Lead message development for key milestones, clinical readouts, regulatory updates, financings, grant awards, and commercial progress • Track and report investor sentiment, sector trends, competition, and peer communications to inform executive decisions and positioning • Manage IR/PR agency relationships to support execution, visibility, and crisis response • Prepare executives for investor meetings, speaking engagements, and media with tailored briefings and coaching • Operationalize a recurring investor-update cadence, including quarterly reports, post-Board updates, and ad hoc news flow • Translate internal insights into investor-facing narrative • Partner with Clinical, Regulatory, CMC, Legal, and Finance to ensure technical accuracy, compliance, and alignment in public-facing documents • Support internal communications and collaborate with Corporate Operations for consistency across internal and external messaging • Contribute to Board materials and corporate reporting tied to strategic communications and investor engagement • Support presence at scientific conferences, trade shows, and investor events • Contribute to pre-commercial positioning as programs advance • Perform other duties as assigned
• Exceptional written and verbal communication, with the ability to translate complex scientific and financial information into clear, compelling messaging • Proven ability to lead IR strategy and manage buy- and sell-side relationships in biotech or life sciences • Deep understanding of the pre-commercial biotech landscape, capital markets, development milestones, and regulatory communications • Strong organizational and project-management skills against tight, high-stakes deadlines • Sound, independent judgment in a fast-paced, dynamic environment • Comfort serving as a public-facing representative across external communications and events • Discretion and professionalism with sensitive or confidential information • Bachelor's degree required • 8–12 years in investor relations, corporate communications, or strategic finance within biotech, pharma, orthopedics, or healthcare • Demonstrated experience supporting or leading investor communications at a pre- or early-commercial life-sciences company • Experience coordinating across Clinical, Regulatory, Legal, and Finance for compliant, accurate external messaging • Advanced degree (MBA, MS, or equivalent) in life sciences, finance, or communications strongly preferred • Orthopedic and MedTech market experience • Experience overseeing corporate websites and social channels for investor/reputational communications • Familiarity with SEC regulations and disclosure practices relevant to private and public biotech • Direct experience with PR/IR agencies and cross-channel campaigns • Background in financial analysis or capital markets; ability to interpret market sentiment and peer performance • Prior involvement in crossover rounds, IPO positioning, or strategic partnerships
Postuler Maintenant🕒 il y a 1 mois
Nonprofit communications director advancing amyloidosis research, advocacy, fundraising, and patient engagement at ARC. Leading brand, digital, campaigns, content, vendors, and communications measurement.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Vice President leading internal communications for Risepoint, an education technology company serving universities. Shaping executive messaging, employee engagement, culture, and communication strategy across a remote-first workforce.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 mois
Director developing high-stakes communications and reputation strategies for Palette’s creator-economy marketing agency. Advising brands, institutions, and public figures across media, politics, culture, and emerging digital channels.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
External Communications Strategist III at PMI driving earned media opportunities and narrative enablement. Collaborating with PR, Marketing, and senior stakeholders to enhance corporate reputation and thought leadership.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Global Director of Strategic Communications developing infrastructure for local environmental voices amid changing media landscapes. Elevating and coaching local stakeholders across various countries and contexts to mainstream conservation efforts.
🗣️🇺🇸🇬🇧 Anglais requis